The new manufacturing site would be able to produce several hundred of million doses of mRNA-based vaccines per year, depending on the type, BioNTech said. Source

JOIN NCOV.LINK NEWSLETTER

And get notified everytime we publish a new Important announcements. We will not email you often, unless there are important things that need to get in touch with you, such as added new tools or new domain names.